EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Metabolomic Insights Into Saliva as a Non‐Invasive Surrogate for Serum to Enable Community‐Based Biomarker Investigation

Alireza Abdshah, Mohammad Alyamani, Robert A Burgess, Dipen J Parekh, Benjamin Spieler, Rakesh Singal, Matthew C Abramowitz, Jaime R Merchan, Lucia Pannunzio, Brandon A Mahal, Erin Kobetz, Sanoj Punnen und 2 weitere

The Prostate · 2026-05 · 86 (7) · 771-783

DOI: 10.1002/pros.70144 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Prostate, online erschienen am 23.02.2026. Verfasst von Alireza Abdshah und 13 weiteren Autor:innen. Beteiligte Einrichtung: Desai Sethi Urology Institute, University of Miami Miller School of Medicine, Miami, Florida, USA. Hauptthemen laut MEDLINE: Saliva, Metabolomics, Prostatic Neoplasms, Biomarkers, Tumor. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIH HHS, National Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Using serum metabolomics in Community‐Based Participatory Research (CBPR) with underserved populations presents challenges due to the invasive nature of venipuncture, which limits longitudinal sample collection in community settings. In this pilot study, we compared saliva and serum metabolomics in patients with prostate cancer to evaluate saliva's potential in biomarker research and identified metabolic changes associated with androgen deprivation therapy (ADT).

Methods

Blood and saliva were collected from 20 eugonadal patients with prostate cancer and 20 patients receiving ADT. Untargeted metabolomics of metabolites was performed, and glucocorticoids were quantified using targeted metabolomics. Data were analyzed using MassHunter, METLIN database, and MetaboAnalyst.

Results

Across all samples, 1198 metabolites were identified. Comparing ADT to eugonadal serum and integrating fold change (FC > 2 or FC < 0.5) and significance (adjusted p < 0.1), we identified 14 upregulated and 20 downregulated metabolites. Comparing ADT to eugonadal saliva, we identified 14 upregulated and 28 downregulated metabolites. Targeted metabolomics confirmed correlations between serum and salivary cortisol and salivary and serum cortisone ( r = 0.61 and 0.62, p < 0.001), underscoring the potential of saliva glucocorticoids as biomarkers for stress‐related metabolic alterations and suggesting that saliva reflects the systemic metabolomic profile.

Conclusion

ADT‐associated metabolomic changes are detectable in saliva. Targeted analysis suggests that salivary glucocorticoids may serve as biomarkers of metabolism and stress in community‐based studies. Our findings support saliva as a non‐invasive alternative to serum for biomarker research, facilitating community‐based investigations and advancing public health efforts.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SalivaMetabolomicsProstatic NeoplasmsBiomarkers, TumorHumansMalePilot ProjectsAgedBiomarkersMiddle AgedAndrogen AntagonistsCommunity-Based Participatory ResearchHydrocortisone

Stichwörter der Autor:innen

androgen deprivation therapymetabolomic profilingnon‐invasive biomarkerssaliva‐serum comparisonsystemic metabolism

Substanzen

Biomarkers, TumorBiomarkersAndrogen AntagonistsHydrocortisone

Autor:innen und Institutionen

  • Desai Sethi Urology Institute, University of Miami Miller School of Medicine, Miami, Florida, USA.
  • Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, Florida, USA.
  • Department of Radiation Oncology, University of Miami Miller School of Medicine, Miami, Florida, USA.
  • Department of Medicine, Medical Oncology Division, University of Miami Miller School of Medicine, Miami, Florida, USA.
  • Department of Public Health Sciences, University of Miami Miller School of Medicine, Miami, Florida, USA.
  • Department of Medicine, University of Miami Miller School of Medicine, Miami, Florida, USA.

ORCID-Profile: Nima Sharifi

Förderung

  • NIH HHS
  • National Science Foundation

Zitieren

APA

Abdshah, A., Alyamani, M., Burgess, R. A., Parekh, D. J., Spieler, B., Singal, R., Abramowitz, M. C., Merchan, J. R., Pannunzio, L., Mahal, B. A., Kobetz, E., Punnen, S., Bilusic, M., & Sharifi, N. (2026). Metabolomic Insights Into Saliva as a Non‐Invasive Surrogate for Serum to Enable Community‐Based Biomarker Investigation. The Prostate, 86(7), 771-783. https://doi.org/10.1002/pros.70144

Vancouver

Abdshah A, Alyamani M, Burgess RA, Parekh DJ, Spieler B, Singal R, et al. Metabolomic Insights Into Saliva as a Non‐Invasive Surrogate for Serum to Enable Community‐Based Biomarker Investigation. The Prostate. 2026;86(7):771-783. doi:10.1002/pros.70144

BibTeX
@article{Abdshah2026,
  author = {Abdshah, Alireza and Alyamani, Mohammad and Burgess, Robert A and Parekh, Dipen J and Spieler, Benjamin and Singal, Rakesh and Abramowitz, Matthew C and Merchan, Jaime R and Pannunzio, Lucia and Mahal, Brandon A and Kobetz, Erin and Punnen, Sanoj and Bilusic, Marijo and Sharifi, Nima},
  title = {Metabolomic Insights Into Saliva as a Non‐Invasive Surrogate for Serum to Enable Community‐Based Biomarker Investigation},
  journal = {The Prostate},
  year = {2026},
  volume = {86},
  number = {7},
  pages = {771--783},
  doi = {10.1002/pros.70144}
}
Kostenlos starten →